When access to care is inadequate, we need public health solutions.
In cities where trust between families and healthcare systems has long been fractured by history and circumstance, a small but telling study offers a different kind of medicine: the presence of someone who already belongs to the community. Trained community health workers in Chicago and Boston helped minority families navigate the labyrinth of ADHD care — not through clinical authority, but through shared language, dismantled stigma, and practical guidance. The results, modest in sample size but significant in direction, suggest that the distance between a diagnosis and meaningful treatment may be bridged less by new drugs or new clinics than by the right human being in the right room.
- Black, Hispanic, and Asian children with ADHD are being left behind — receiving fewer doctor visits, less medication, and less behavioral support than their white peers, with consequences that ripple into classrooms, families, and courtrooms.
- The barriers are not simply logistical: beneath the transportation gaps and insurance walls lies a deeper wound — generations of discrimination that make many families distrust the very institutions meant to help them.
- A six-hour intervention led by community health workers — neighbors, not clinicians — confronted myths, reduced stigma, and taught caregivers how to advocate for their children within a system that has often overlooked them.
- Among the 15 families who completed the program, therapy use more than doubled, school accommodations jumped from 38% to 88%, and nearly all caregivers said they felt more confident pursuing treatment afterward.
- Researchers are now preparing a larger randomized trial, betting that what worked in this careful pilot can be scaled into a genuine public health solution for one of childhood's most undertreated conditions.
A pilot study has found that community health workers — people without clinical credentials but with deep roots in their neighborhoods — can meaningfully shift how families engage with ADHD treatment. Published in the Journal of Attention Disorders, the intervention involved six-hour programs where these workers discussed evidence-based care, confronted myths, addressed stigma, and taught families how to navigate the healthcare system. Among the 15 caregivers who completed the program, medication use rose from 38% to 50%, therapy use jumped from 31% to 69%, and school accommodations nearly doubled from 38% to 88%.
The work addresses a persistent gap: Black, Hispanic, and Asian children with ADHD receive substantially less treatment than their white peers. The reasons are layered — transportation barriers, insurance gaps, childcare logistics, and the accumulated weight of stigma and discrimination that shapes whether a family feels welcome in a clinic at all. Dr. Andrea Spencer of Ann & Robert H. Lurie Children's Hospital of Chicago framed the stakes plainly: ADHD affects 6 to 8 percent of children and, without treatment, can lead to educational struggles, family conflict, and justice involvement. Treatment works — but access remains unequal.
The intervention was designed with input from a Community Advisory Board that included caregivers of color, school staff, clinicians, and health equity researchers. Nearly 88 percent of participants said the program was helpful, and 94 percent reported feeling more confident seeking treatment afterward. Feedback on stigma reduction was particularly strong — caregivers said the program helped them confront internalized stigma and gave them tools to respond to it from others.
The pilot's numbers are small, but the direction is clear. Spencer and her team are now planning a larger randomized clinical trial to test whether these results hold at scale. What began as a careful test of whether community health workers could move the needle on a stubborn disparity has generated enough evidence to warrant the next phase.
A pilot study has found that trained community health workers—people without clinical credentials but with deep roots in their neighborhoods—can meaningfully shift how families engage with ADHD treatment. The intervention, published in the Journal of Attention Disorders, centered on six-hour programs where these workers discussed evidence-based care, confronted myths, addressed stigma, and taught families how to navigate the healthcare system and advocate for their children. Among the 15 caregivers who completed the program, the results were striking: medication use rose from 38% to 50%, therapy use jumped from 31% to 69%, and school accommodations nearly doubled from 38% to 88%.
The work addresses a persistent and well-documented gap. Black, Hispanic, and Asian children with ADHD receive substantially less treatment than their white peers—fewer doctor visits, lower rates of medication, less access to behavioral support. The reasons are layered: transportation barriers, insurance gaps, childcare logistics, and the weight of stigma. But there is also something harder to name—the accumulated experience of discrimination and implicit bias that shapes whether a family feels welcome in a clinic or trusts the advice they receive there.
Dr. Andrea Spencer, who leads the research at Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University, framed the problem in public health terms. ADHD affects roughly 6 to 8 percent of children and can have lifelong consequences—educational struggles, family conflict, involvement with the justice system. Treatment works. A combination of FDA-approved medication, behavioral therapy, and school accommodations reduces symptoms and improves outcomes. Yet access remains unequal. "When so many children have an illness and access to care is inadequate, we need to think beyond individual patient interactions and develop public health solutions," Spencer said.
The intervention was designed with input from a Community Advisory Board that included caregivers of color, school staff, clinicians, and health equity researchers. The content was refined based on feedback from participants. Nearly all caregivers—88 percent—agreed or strongly agreed the program was helpful. Ninety-four percent reported feeling more confident seeking treatment afterward. Many said the program made them more likely to pursue medications, therapy, and school services. The feedback on stigma reduction was particularly strong. Caregivers said the intervention helped them confront their own internalized stigma about ADHD and gave them tools to respond to stigma from others.
The pilot enrolled 18 caregivers of children aged 6 to 12 with recently diagnosed ADHD. Fifteen completed the full intervention, 16 completed all study questionnaires, and 13 participated in exit interviews. The numbers are small, but the direction is clear. The percent of children receiving outpatient treatment services increased across the board. The increase in school accommodations—from 38 to 88 percent—was statistically significant.
Spencer and her team are now planning a larger randomized clinical trial to test whether these results hold at scale. The goal is explicit: to improve outcomes for children with ADHD, especially those from Black, Hispanic, Asian, and other minoritized communities. The research was conducted at Boston Medical Center and Boston University's Chobanian & Avedisian School of Medicine. What began as a pilot—a small, careful test of whether community health workers could move the needle on a stubborn disparity—has generated enough evidence to warrant the next phase. The question now is whether this approach, already proven effective for conditions like asthma, can reshape how families access and engage with ADHD care.
Citas Notables
When so many children have an illness and access to care is inadequate, we need to think beyond individual patient interactions and develop public health solutions.— Dr. Andrea Spencer, lead researcher
We received overwhelmingly positive feedback about the content and strategy addressing stigma in particular. A community-based approach really can change the stigma associated with ADHD and hopefully get more kids into treatment.— Dr. Andrea Spencer
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that community health workers delivered this intervention rather than doctors or therapists?
Because trust and access are inseparable. A community health worker lives in the neighborhood. They understand the specific barriers families face—which clinics have evening hours, which ones require insurance upfront, which ones have a history with the community. They're not an outsider in a white coat. That changes what people feel safe saying.
The study mentions stigma reduction as particularly important. What kind of stigma are we talking about?
Both internal and external. Some parents internalize the idea that ADHD is a character flaw or a sign they've failed as a parent. Others worry about how their child will be perceived at school or in the community. And then there's the real discrimination—teachers who dismiss ADHD as an excuse, clinicians who don't take Black or Hispanic parents seriously when they describe their child's symptoms. The intervention addressed all of it.
The numbers show medication use went from 38 to 50 percent. That's significant but not transformative. Why?
It's significant precisely because it's real. These aren't people who were already close to seeking treatment. These are families facing genuine barriers. A 12-point increase in medication use means dozens of children getting access to something that works. And the school accommodations number—38 to 88 percent—that's transformative. That's families learning they have rights and learning how to claim them.
What happens next?
A larger trial. They need to know if this works beyond this small pilot group, and whether the effects last. But the real question is whether the healthcare system is ready to fund and scale this. Community health workers are cheaper than clinicians, but they require training, supervision, and ongoing support. The evidence has to be compelling enough to justify the investment.